HVTN 505 vaccine induced antibodies nonspecific for HIV

30 julio 2015

A new study helps explain why the candidate vaccine used in the HVTN 505 clinical trial was not protective against HIV infection despite robustly inducing anti-HIV antibodies: the vaccine stimulated antibodies that recognized HIV as well as microbes commonly found in the intestinal tract, part of the body’s microbiome.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/FFKV7jFZSPI» height=»1″ width=»1″ alt=»»/